Pfizer’s counterattack against 13 domestic companies

Pfizer which successfully protected the ‘Lyrica’ use patent started to counterattack. It has continued lawsuits against domestic companies which launched generics.

Pfizer Pharmaceuticals Korea filed a damage suit accusing of using the Lyrica’s(pregabalin) pain indications against CJ HealthCare and Samjin Pharm to the Seoul Central District Court on the 29^th last month.

Recently, moreover, i...